THE FOUNDATION FOR AIDS RESEARCH: Form 990, tax year 2014
View the entire original 990 at ProPublica ↗
- Organization
- THE FOUNDATION FOR AIDS RESEARCH (EIN 13-3163817)
- Tax period
- 2014-10-01 to 2015-09-30
- Filed
- 2016-06-03
- IRS object ID
- 201641559349300129
- Schema version
- 2014v6.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2016-06-03T12:57:48-05:00 | ReturnTs |
| Tax Period End | 2015-09-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GRANT THORNTON LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 757 THIRD AVE 4TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100172013 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2014-10-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 133163817 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE FOUNDATION FOR AIDS RESEARCH | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % BRADLEY JENSEN | InCareOfNm |
| Business Name Control | FOUN | BusinessNameControlTxt |
| Phone | 2128061600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 wall street 13TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100053908 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Brad Jensen | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 2125990100 | PhoneNum |
| Signature | 2016-06-02 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Scott Thompsett | PreparerPersonNm |
| PTIN | P00741490 | PTIN |
| Phone | 2125990100 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2014 | TaxYr |
| Build TS | 2016-08-17 19:52:53Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Aids Research Foundation or AMFAR | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | KEVIN FROST | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 WALL STREET 13TH FLOOR | AddressLine1Txt |
| City | new york | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10005 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $72,911,885 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.AMFAR.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1983 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | amfar is dedicated to ending the global AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 19 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 19 | VotingMembersIndependentCnt |
| Total Employee | 88 | TotalEmployeeCnt |
| Total Volunteers | 57 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $57,556,516 | PYContributionsGrantsAmt |
| CY Contributions Grants | $56,251,128 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,225,465 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,528,180 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$10,881,866 | PYOtherRevenueAmt |
| CY Other Revenue | -$10,047,530 | CYOtherRevenueAmt |
| PY Total Revenue | $47,900,115 | PYTotalRevenueAmt |
| CY Total Revenue | $47,731,778 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $9,928,384 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $9,528,182 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $9,582,859 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $10,307,568 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $569,004 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $739,793 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $5,533,456 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $14,312,877 | PYOtherExpensesAmt |
| CY Other Expenses | $17,000,831 | CYOtherExpensesAmt |
| PY Total Expenses | $34,393,124 | PYTotalExpensesAmt |
| CY Total Expenses | $37,576,374 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $13,506,991 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $10,155,404 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $57,895,971 | TotalAssetsBOYAmt |
| Total Assets EOY | $71,251,093 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $13,585,624 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $18,212,471 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $44,310,347 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $53,038,622 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE FOUNDATION FOR AIDS RESEARCH IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN NEW YORK IN 1989. AMFAR WAS FORMED THROUGH THE UNIFICATION IN 1985 OF TWO NOT-FOR-PROFIT ORGANIZATIONS, THE AIDS MEDICAL FOUNDATION ("AMF"), INCORPORATED IN NEW YORK IN APRIL 1983, AND THE NATIONAL AIDS RESEARCH FOUNDATION, INCORPORATED IN CALIFORNIA IN AUGUST 1985. FIRST BASED IN CALIFORNIA, AMFAR TRANSFERRED ITS LEGAL DOMICILE TO NEW YORK IN 1989, USING THE INITIAL INCORPORATION DOCUMENTS OF AMF, MAKING IT AMF'S LEGAL SUCCESSOR. AMFAR HAS OFFICES IN NEW YORK, NY, WASHINGTON, D.C., AND BANGKOK, THAILAND. ON MARCH 7, 2005, THE BOARD OF TRUSTEES OF THE AMERICAN FOUNDATION FOR AIDS RESEARCH APPROVED A CHANGE IN LEGAL NAME TO "THE FOUNDATION FOR AIDS RESEARCH." ON OCTOBER 18, 2005, THE NEW YORK STATE DEPARTMENT OF STATE APPROVED THIS CHANGE. IN ADDITION, THE FOUNDATION HAS SECURED APPROVAL FOR DOING BUSINESS AS (DBA) THE FOLLOWING: - AMERICAN FOUNDATION FOR AIDS RESEARCH - AMFAR - AIDS RESEARC | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $15,140,613 | ExpenseAmt |
| Grant | $5,330,808 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | RESEARCH: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $5,807,363 | ExpenseAmt |
| Grant | $2,833,778 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | TREAT ASIA: amfAR's TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies. The TREAT Asia Network encompasses 21 adult and 18 pediatric sites throughout the region, which collaborate on a variety of projects. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $4,236,913 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)
| ExpenseExpenseAmt | GrantGrantAmt | RevenueRevenueAmt | DescDesc |
|---|---|---|---|
| $2,360,664 | $1,231,676 | $0 | GMT Initiative |
| $2,043,887 | $131,920 | $0 | public policy |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $4,404,551 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $1,363,596 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $0 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $29,589,440 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | Yes (true) | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 142 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 88 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | TH | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 19 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 19 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | BRADLEY JENSEN | PersonNm |
| Phone | 2128061703 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 WALL STREET 13TH FLOOR | AddressLine1Txt |
| City | new york | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100053908 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| Mathilde Krim PhD | |||||||||
| Founding Chairman | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Kenneth Cole | |||||||||
| Chairman of the Board | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Patricia J Matson | |||||||||
| Vice Chairman | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| John C Simons | |||||||||
| Vice Chairman | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Wallace Sheft CPA | |||||||||
| Treasurer (thru 09/2015) | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Mervyn F Silverman MDMPH | |||||||||
| Secretary | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Arlen H Andelson | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Harry Belafonte | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| David Bohnett | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Zev Braun | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Jonathan S Canno | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Donald Capoccia | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| R Martin Chavez PhD | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Jane B Eisner | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| T Ryan Greenawalt | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Regan Hofmann | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Michael J Klingensmith | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Kevin McClatchy | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Michele V McNeill PharmD | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Edward Milstein | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Cindy Rachofsky | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Vincent A Roberti | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Bill Roedy | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Raymond F Schinazi PhD | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Alan D Schwartz | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Diana L Taylor | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Kevin Wendle | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Kevin Frost | |||||||||
| Chief Executive Officer | 40.0 | 0.0 | Yes (X) | $520,359 | $0 | $86,809 | |||
| Bradley Jensen | |||||||||
| Assistant Treasurer, CFO | 40.0 | 0.0 | Yes (X) | $236,484 | $0 | $53,305 | |||
| John F Logan JD PhD | |||||||||
| AssT Sec, Vp, GEN COUNSEL | 40.0 | 0.0 | Yes (X) | $219,864 | $0 | $27,414 | |||
| Rowena Johnston | |||||||||
| Asst Secretary, Vice President | 40.0 | 0.0 | Yes (X) | $180,441 | $0 | $24,608 | |||
| Edward Donnelly | |||||||||
| Asst Treasurer, Controller | 40.0 | 0.0 | Yes (X) | $145,201 | $0 | $21,525 | |||
| Eric Muscatell | |||||||||
| Vice President of Development | 40.0 | 0.0 | $197,610 | $0 | $25,938 | Yes (X) | |||
| AnnMarie Shannahan | |||||||||
| Vice President, Public Info. | 40.0 | 0.0 | $208,911 | $0 | $26,630 | Yes (X) | |||
| Gregorio Millet | |||||||||
| Vice President, Public Policy | 40.0 | 0.0 | $112,119 | $0 | $7,729 | Yes (X) | |||
| Andrew McInness | |||||||||
| Director, Publications | 40.0 | 0.0 | $148,469 | $0 | $47,255 | Yes (X) | |||
| Anthony Ancona | |||||||||
| Vice President, Human Resource | 40.0 | 0.0 | $167,055 | $0 | $23,734 | Yes (X) | |||
| Susan Doster | |||||||||
| Chief Technology Officer | 40.0 | 0.0 | $136,579 | $0 | $38,133 | Yes (X) | |||
| Bennah Serfaty | |||||||||
| Sr Director of CommunicatiON | 40.0 | 0.0 | $118,344 | $0 | $45,064 | Yes (X) | |||
| Raoul Norman Tenazas | |||||||||
| Creative Director | 40.0 | 0.0 | $114,699 | $0 | $44,932 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,506,135 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $473,076 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 20 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| AAB PRODUCTION INC | |||||
| 64 ALLEN STREET 5TH FLOOR | NEW YORK | NY | 10002 | events production | $556,354 |
| JOSH WOODS PRODUCTION | |||||
| 39 WEST 14TH STREET SUITE 504 | NEW YORK | NY | 10011 | Events Production | $522,240 |
| EIDOLON Communications Inc | |||||
| 15 Maiden Lane Suite 1401 | NEW YORK | NY | 10038 | Direct Mail/Consult. | $257,093 |
| Changing Our World Inc | |||||
| 220 East 42nd Street 5th Floor | NEW YORK | NY | 10017 | Philanthropic Adviso | $210,000 |
| King Company | |||||
| 101 Fifth Avenue 8th Floor | NEW YORK | NY | 10003 | Public Relations | $194,450 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 9 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $288,202 | FederatedCampaignsAmt |
| Fundraising | $34,114,106 | FundraisingAmt |
| Government Grants | $10,220,999 | GovernmentGrantsAmt |
| All Other Contributions | $11,627,821 | AllOtherContributionsAmt |
| Noncash Contributions | $631,638 | NoncashContributionsAmt |
| Total Contributions | $56,251,128 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,597,243 | TotalRevenueColumnAmt |
| Exclusion | $1,597,243 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $55,532 | TotalRevenueColumnAmt |
| Exclusion | $55,532 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $12,906,804 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $12,975,867 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$69,063 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$69,063 | TotalRevenueColumnAmt |
| Exclusion | -$69,063 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $1,871,885 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $34,114,106 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $12,158,631 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$10,286,746 | TotalRevenueColumnAmt |
| Exclusion | -$10,286,746 | ExclusionAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $212,642 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $45,609 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $167,033 | TotalRevenueColumnAmt |
| Exclusion | $167,033 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| LIST RENTALS | 900099 | $4,637 | $4,637 |
| STORE SALES | 900099 | $2,411 | $2,411 |
| MISCELLANEOUS INCOME | 900099 | $9,603 | $9,603 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $16,651 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $47,731,778 | TotalRevenueColumnAmt |
| Exclusion | -$8,519,350 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,135,665 | TotalAmt |
| Program Services | $4,135,665 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,392,517 | TotalAmt |
| Program Services | $5,392,517 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,507,490 | TotalAmt |
| Program Services | $1,825,227 | ProgramServicesAmt |
| Management And General | $324,827 | ManagementAndGeneralAmt |
| Fundraising | $357,436 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,683,653 | TotalAmt |
| Program Services | $3,788,075 | ProgramServicesAmt |
| Management And General | $590,969 | ManagementAndGeneralAmt |
| Fundraising | $1,304,609 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $349,208 | TotalAmt |
| Program Services | $234,458 | ProgramServicesAmt |
| Management And General | $41,865 | ManagementAndGeneralAmt |
| Fundraising | $72,885 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,246,045 | TotalAmt |
| Program Services | $795,117 | ProgramServicesAmt |
| Management And General | $168,706 | ManagementAndGeneralAmt |
| Fundraising | $282,222 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $521,172 | TotalAmt |
| Program Services | $339,231 | ProgramServicesAmt |
| Management And General | $62,228 | ManagementAndGeneralAmt |
| Fundraising | $119,713 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $91,139 | TotalAmt |
| Program Services | $66,900 | ProgramServicesAmt |
| Management And General | $24,239 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $198,754 | TotalAmt |
| Management And General | $198,754 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $49,547 | TotalAmt |
| Program Services | $49,547 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $739,793 | TotalAmt |
| Fundraising | $739,793 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $249,454 | TotalAmt |
| Management And General | $249,454 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,057,215 | TotalAmt |
| Program Services | $1,561,504 | ProgramServicesAmt |
| Management And General | $38,500 | ManagementAndGeneralAmt |
| Fundraising | $457,211 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $306,946 | TotalAmt |
| Program Services | $305,602 | ProgramServicesAmt |
| Management And General | $1,344 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $70,929 | TotalAmt |
| Program Services | $40,284 | ProgramServicesAmt |
| Management And General | $6,124 | ManagementAndGeneralAmt |
| Fundraising | $24,521 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $265,528 | TotalAmt |
| Program Services | $193,685 | ProgramServicesAmt |
| Management And General | $32,626 | ManagementAndGeneralAmt |
| Fundraising | $39,217 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,226,763 | TotalAmt |
| Program Services | $886,102 | ProgramServicesAmt |
| Management And General | $144,137 | ManagementAndGeneralAmt |
| Fundraising | $196,524 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,022,253 | TotalAmt |
| Program Services | $522,799 | ProgramServicesAmt |
| Management And General | $2,698 | ManagementAndGeneralAmt |
| Fundraising | $496,756 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $953,805 | TotalAmt |
| Program Services | $829,472 | ProgramServicesAmt |
| Management And General | $15,061 | ManagementAndGeneralAmt |
| Fundraising | $109,272 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $42 | TotalAmt |
| Management And General | $42 | ManagementAndGeneralAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $376,133 | TotalAmt |
| Program Services | $273,099 | ProgramServicesAmt |
| Management And General | $44,424 | ManagementAndGeneralAmt |
| Fundraising | $58,610 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $283,781 | TotalAmt |
| Program Services | $206,045 | ProgramServicesAmt |
| Management And General | $33,516 | ManagementAndGeneralAmt |
| Fundraising | $44,220 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| PROGRAM MATERIALS | $6,100,273 | $6,100,273 | $0 | $0 |
| PROGRAM TECHNICAL SUPPORT | $878,543 | $878,543 | $0 | $0 |
| POSTAGE & SHIPPING | $778,733 | $357,116 | $4,661 | $416,956 |
| PRINTING | $710,268 | $185,971 | $492 | $523,805 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,380,725 | TotalAmt |
| Program Services | $622,208 | ProgramServicesAmt |
| Management And General | $468,811 | ManagementAndGeneralAmt |
| Fundraising | $289,706 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $37,576,374 | TotalAmt |
| Program Services | $29,589,440 | ProgramServicesAmt |
| Management And General | $2,453,478 | ManagementAndGeneralAmt |
| Fundraising | $5,533,456 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $902,280 | TotalAmt |
| Program Services | $277,069 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $625,211 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,961,745 | BOYAmt |
| EOY | $18,387,580 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $323,338 | BOYAmt |
| EOY | $323,338 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $369,693 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,045,656 | BOYAmt |
| EOY | $6,118,590 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $213,295 | BOYAmt |
| EOY | $191,382 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,475,828 | BOYAmt |
| EOY | $1,480,222 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $6,133,384 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $3,844,450 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,230,700 | BOYAmt |
| EOY | $2,288,934 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $40,982,916 | BOYAmt |
| EOY | $39,666,715 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,101,105 | BOYAmt |
| EOY | $1,069,137 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $561,388 | BOYAmt |
| EOY | $1,355,502 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $57,895,971 | BOYAmt |
| EOY | $71,251,093 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,132,495 | BOYAmt |
| EOY | $3,435,700 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,547,120 | BOYAmt |
| EOY | $3,049,552 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,166,426 | BOYAmt |
| EOY | $10,067,061 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,739,583 | BOYAmt |
| EOY | $1,660,158 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,585,624 | BOYAmt |
| EOY | $18,212,471 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,819,754 | BOYAmt |
| EOY | $48,874,571 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,143,351 | BOYAmt |
| EOY | $3,808,811 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $347,242 | BOYAmt |
| EOY | $355,240 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $44,310,347 | BOYAmt |
| EOY | $53,038,622 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $57,895,971 | BOYAmt |
| EOY | $71,251,093 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $10,155,404 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$1,429,685 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $2,556 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $22,876,129 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $33,247,849 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $38,582,579 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $57,556,516 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $56,251,128 | CurrentTaxYearAmt |
| Total | $208,514,201 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $22,876,129 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $33,247,849 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $38,582,579 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $57,556,516 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $56,251,128 | CurrentTaxYearAmt |
| Total | $208,514,201 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $3,374,428 | SubstantialContributorsTotAmt |
| Public Support Total170 | $205,139,773 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $951,963 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $897,974 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $755,293 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $804,366 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,652,775 | CurrentTaxYearAmt |
| Total | $5,062,371 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,735,330 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,624,966 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,467,184 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,693,403 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,101,178 | CurrentTaxYearAmt |
| Total | $8,622,061 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $222,198,633 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $0 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.92323 | PublicSupportCY170Pct |
| Public Support PY170 | 0.90386 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | false | DirectContactLegislatorsInd |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $199,739 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $199,739 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
| Form4720 Filed4912 Tax | false | Form4720Filed4912TaxInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Lobbying Expenses | FormAndLineReferenceDesc |
| Explanation | Part II-B The Foundation for AIDS Research developed an Action Agenda to End AIDS that identified critical decisions that need to be made to advance evidence based AIDS policies. We created a variety of issue briefs on topics such as the potential impact of various budget scenarios on global health services, and policy priorities to address the HIV epidemic among gay men in the US. These issue briefs were shared with Capitol Hill staff and members of the Administration. amfAR met regularly with staff to members of Congress and with Administration staff, and we provided input to the Administration on development of the PEPFAR Blueprint for an AIDS Free Generation. amfAR sponsored several briefings on Capitol Hill on AIDS policy and research issues. amfAR uses these briefings as an educational tool. | ExplanationTxt |
Schedule D IRS990ScheduleD
Art Public Exhibition Amounts ArtPublicExhibitionAmountsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Assets Included | $213,703 | AssetsIncludedAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Held Works Art | HeldWorksArtGrp |
Collection Used Other Purposes CollectionUsedOtherPurposesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Collection Used Other Purposes | Yes (X) | CollectionUsedOtherPurposesInd |
| Other Purposes | Donated Items, Inventory etc. | OtherPurposesDesc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Solicited Assets Sale | Yes (true) | SolicitedAssetsSaleInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $490,979 | BeginningYearBalanceAmt |
| Contributions | $7,998 | ContributionsAmt |
| Investment Earnings Or Losses | -$5,941 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $493,036 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $443,886 | BeginningYearBalanceAmt |
| Contributions | $6,543 | ContributionsAmt |
| Investment Earnings Or Losses | $40,550 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $490,979 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $520,804 | BeginningYearBalanceAmt |
| Contributions | $3,211 | ContributionsAmt |
| Investment Earnings Or Losses | $20,742 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $100,871 | OtherExpendituresAmt |
| End Year Balance | $443,886 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $464,356 | BeginningYearBalanceAmt |
| Contributions | $4,341 | ContributionsAmt |
| Investment Earnings Or Losses | $52,107 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $520,804 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $561,083 | BeginningYearBalanceAmt |
| Contributions | $5,978 | ContributionsAmt |
| Investment Earnings Or Losses | -$2,705 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $100,000 | OtherExpendituresAmt |
| End Year Balance | $464,356 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.00000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.72052 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.27948 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $2,215,917 | OtherCostOrOtherBasisAmt |
| Depreciation | $877,847 | DepreciationAmt |
| Book Value | $1,338,070 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $309,029 | OtherCostOrOtherBasisAmt |
| Depreciation | $279,288 | DepreciationAmt |
| Book Value | $29,741 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $3,608,438 | OtherCostOrOtherBasisAmt |
| Depreciation | $2,687,315 | DepreciationAmt |
| Book Value | $921,123 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $2,288,934 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| LONG TERM LEASE LIABILITY | $1,513,795 |
| SECTION 457 RETIREMENT LIABILITIES | $146,363 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $1,660,158 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $46,610,198 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$1,429,685 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $305,549 | DonatedServicesAndUseFcltsAmt |
| Other Revenue | $2,556 | OtherRevenueAmt |
| Revenue Not Reported | -$1,121,580 | RevenueNotReportedAmt |
| Revenue Subtotal | $47,731,778 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $47,731,778 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $37,881,923 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $305,549 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $305,549 | ExpensesNotReportedAmt |
| Expenses Subtotal | $37,576,374 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $37,576,374 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Endowments | Part V, Line 4 AMFAR's endowment fund is intended to fund the various general research programs the organization sponsors. |
| FIN 48 | Income taxes Amfar follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and guidance on measurement. This guidance provides that the tax effects from an uncertain tax position can only be recognized in the financial statements if the position is "more-likely-than-not" to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. Amfar has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. The tax years ended SEPTEMBER 30, 2012, 2013, 2014 and 2015 are still open to audit for both federal and state purposes. amfAR has determined that there are no material uncertain tax positions that require recognition or disclosure in the financial statements. |
| reconciliation of revenue | part XI, Line 2d change in value for third party trust $2,556 |
| Collections of Art, Historical Treasures, or other similar assets | Part III, Line 4 AMFAR holds various items of jewelry, photographs and other items of artistic value that have been donated to the organization for sale at special events. The organization has maintained these items in inventory for a few years and is in the process of selling them. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | OfficesOfficesCnt | EmployeeEmployeeCnt |
|---|---|---|---|---|---|
| Central America and the Caribbean | Grantmaking | N/A | $35,000 | ||
| East Asia and the Pacific | Grantmaking | N/A | $3,258,027 | ||
| Europe (Including Iceland and Greenland) | Grantmaking | N/A | $874,724 | ||
| North America | Grantmaking | N/A | $610,913 | ||
| South America | Grantmaking | N/A | $398,624 | ||
| South Asia | Grantmaking | N/A | $100,684 | ||
| Sub-Saharan Africa | Grantmaking | N/A | $114,545 | ||
| East Asia and the Pacific | Program Services | THERAPEUTICS, TRAINING | $5,108,145 | 1 | 22 |
| Europe (Including Iceland and Greenland) | Fundraising | N/A | $12,944,557 | ||
| South America | Fundraising | N/A | $549,245 | ||
| South Asia | Fundraising | N/A | $1,943,338 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 1 | SubtotalOfficesCnt |
| Subtotal Employees | 22 | SubtotalEmployeesCnt |
| Total Office | 1 | TotalOfficeCnt |
| Total Employee | 22 | TotalEmployeeCnt |
| Subtotal Spent | $25,937,802 | SubtotalSpentAmt |
| Total Spent | $25,937,802 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (70 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| Caribbean/Central America | GMT INITIATIVE | $25,000 | wire transfe |
| East Asia/Pacific | BASIC RESEARCH | $60,000 | wire transfe |
| East Asia/Pacific | BASIC RESEARCH | $47,240 | wire transfe |
| East Asia/Pacific | BASIC RESEARCH | $124,983 | wire transfe |
| East Asia/Pacific | GMT INITIATIVE | $25,000 | wire transfe |
| East Asia/Pacific | GMT INITIATIVE | $25,000 | wire transfe |
| East Asia/Pacific | GMT INITIATIVE | $300,000 | wire transfe |
| East Asia/Pacific | GMT INITIATIVE | $13,271 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $47,338 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $985,866 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $20,320 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $46,800 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $32,890 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,500 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,450 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,300 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,375 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,775 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $71,092 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $32,607 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $127,215 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $11,200 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $9,500 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $66,888 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $107,092 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $93,266 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $29,354 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $15,550 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $15,450 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $11,475 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $46,717 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $15,050 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $20,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $20,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $20,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $19,700 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $73,650 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $20,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,310 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $71,880 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $10,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $12,000 | wire transfe |
| Europe | BASIC RESEARCH | $75,000 | wire transfe |
| Europe | BASIC RESEARCH | $75,000 | wire transfe |
| Europe | BASIC RESEARCH | $60,000 | wire transfe |
| Europe | BASIC RESEARCH | $81,852 | wire transfe |
| Europe | BASIC RESEARCH | $443,407 | wire transfe |
| Europe | BASIC RESEARCH | $74,798 | wire transfe |
| Europe | BASIC RESEARCH | $59,983 | wire transfe |
| Europe | BASIC RESEARCH | $20,000 | wire transfe |
| Europe | BASIC RESEARCH | $9,362 | wire transfe |
| North America (excl USA) | BASIC RESEARCH | $44,444 | wire transfe |
| North America (excl USA) | BASIC RESEARCH | $166,391 | wire transfe |
| North America (excl USA) | BASIC RESEARCH | $400,078 | wire transfe |
| South America | GMT INITIATIVE | $292,226 | wire transfe |
| South America | GMT INITIATIVE | $96,398 | wire transfe |
| South Asia | PUBLIC POLICY | $20,000 | wire transfe |
| South Asia | PUBLIC POLICY | $21,025 | wire transfe |
| South Asia | TREAT ASIA | $19,450 | wire transfe |
| South Asia | TREAT ASIA | $11,595 | wire transfe |
| South Asia | TREAT ASIA | $22,762 | wire transfe |
| South Asia | TREAT ASIA | $9,047 | wire transfe |
| Sub-Saharan Africa | GMT INITIATIVE | $25,000 | wire transfe |
| Sub-Saharan Africa | PREVENTION SCIENCE OUTREACH | $25,000 | wire transfe |
| Sub-Saharan Africa | PUBLIC POLICY | $39,945 | wire transfe |
| Sub-Saharan Africa | PUBLIC POLICY | $10,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $42,600 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $591,568 | wire transfe |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 70 | Total501c3OrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Foreign Activities | Part I, Line 2 International organizations are recommended for funding based upon the results of community-based peer review and/or program staff assessment of proposal merit and organization capacity to undertake proposed projects that are CHARITABLE in purpose. Pre-award due-diligence for new international grantees includes review of organization documents and registrations to verify that the organization operates for a CHARITABLE purpose and that basic capacity for project oversight and governance has been established. All international grantees are required to report semi-annually on project progress and expenditures; continued reporting is required until such time as grant funds are expended in full. Reports are reviewed by administrative and program staff. Additional oversight is provided as necessary by means of ongoing, informal contact with sites regarding progress and technical issues and site visits where feasible. International research grant recipients submit an interim and a final progress reporting addition to expenditures reports due following the ends of the 2nd, 3rd and final quarters of the performance period. |
| foreign activities | Part I, Line 3, Column D The Foundation for AIDS Research conducts many of its grant-making program services (see Part III of Form 990) in U.S. and foreign jurisdictions. In column D, the organization has reported the basic program these grants support; please refer to Part III for more information about these programs/initiatives. |
| Foreign Activities - Status of Grantees | The Foundation for Aids Research supports many non-U.S. organizations in the fight against AIDS and HIV-related diseases. For purposes of Schedule F, Part II, Line 2 - all 149 charities supported are presumed to be the equivalent of U.S. charities. |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Phone Solicitations | Yes (X) | PhoneSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt |
|---|---|---|---|---|---|---|---|---|
| aab productions INC | ||||||||
| 387 Grant Street Suite K705 | New York | NY | 10002 | events production | false | $23,129,015 | $614,956 | $22,514,059 |
| EIDOLON COMMUNICATIONS INC | ||||||||
| 15 Maiden Lane Suite 1401 | New York | NY | 10038 | direct mail | false | $2,131,227 | $270,650 | $1,860,577 |
| public interest communications | ||||||||
| 7700 Leesburg Pike | Falls Church | VA | 22043 | tele marketing | false | $18,728 | $32,099 | -$13,371 |
| Donor Services Group LLC | ||||||||
| 6715 Sunset Blvd | Hollywood | CA | 90028 | Tele marketing | false | $100 | $6,588 | -$6,488 |
| Josh Woods Production | ||||||||
| 245 W 29th Street | New York | NY | 10001 | Special event prod. | false | $7,952,320 | $528,000 | $7,424,320 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $33,231,390 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $1,452,293 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $31,779,097 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | CANNES | Event1Nm |
| Gross Receipts Event1 | $15,990,176 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $15,534,176 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $456,000 | GrossRevenueEvent1Amt |
| Rent Facility Costs Event1 | $1,166,241 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $164,025 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $1,171,125 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $2,236,215 | OtherDirectExpensesEvent1Amt |
| Event2 | DALLAS | Event2Nm |
| Gross Receipts Event2 | $4,102,963 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $3,978,678 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $124,285 | GrossRevenueEvent2Amt |
| Rent Facility Costs Event2 | $261,520 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $155,135 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $73,913 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $554,882 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 16 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $15,892,852 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $14,601,252 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $1,291,600 | GrossRevenueOtherEventsAmt |
| Rent Fclty Costs Other Events | $495,405 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $960,466 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $2,081,591 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $2,838,113 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $35,985,991 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $34,114,106 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $1,871,885 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $1,923,166 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $1,279,626 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $3,326,629 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $5,629,210 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $12,158,631 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$10,286,746 | NetIncomeSummaryAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule G, Part I | FormAndLineReferenceDesc |
| Explanation | The Foundation for AIDS Research actually paid out $739,793 in fundraising expenses for the year ending September 30, 2015. This amount is reported on Part IX, Line 11(e). For purposes of Schedule G, the Foundation is reporting all amounts paid to the consultants listed on Part I, regardless of whether such amounts were pure fundraising expenses or event production costs. On Schedule G, the total amount paid to the organizations listed is $1,452,293. Of that $1,452,293, only $739,793 was paid for fundraising services, the remaining $712,500 was paid for event production services. In the interests of clarity, the foundation would also like to make clear that the compensation reported as having been paid to the professional fundraisers reported on Schedule G is reported on a fiscal year basis. Some of those same fundraisers are reported on the foundation's top 5 highest paid independent contractors list (in Schedule O). In compliance with the instructions to the Form 990, compensation reported for Part VII (and listed in Schedule O) is reported on a calendar year basis. Accordingly, amounts on Part VII and Schedule G will not reconcile. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (33 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd |
|---|---|---|---|---|---|---|---|---|---|---|
| Beth Israel Deaconess Medical Center | ||||||||||
| 330 Brookline Avenue | Boston | MA | 02215 | 042103881 | 501(c)(3) | $124,497 | BASIC RESEARCH | |||
| Blood Systems Inc | ||||||||||
| 270 Masonic Avenue | San Francisco | CA | 941184417 | 860098929 | 501(c)(3) | $60,000 | BASIC RESEARCH | |||
| Case Western Reserve University | ||||||||||
| 10900 Euclid Avenue LC 4930 | Cleveland | OH | 44106 | 341018992 | 501(c)(3) | $321,508 | BASIC RESEARCH | |||
| Charities Aid Foundation of America (CAF America) | ||||||||||
| King Street Station 1800 Diagonal R | Alexandria | VA | 223148931 | 431634280 | 501(c)(3) | $301,163 | PREVENTION SCIENCE OUTREACH | |||
| Cold Spring Harbor Laboratory | ||||||||||
| 1 Bungotwn Road | Cold Spring Habor | NY | 11724 | 112013303 | 501(c)(3) | $12,000 | BASIC RESEARCH | |||
| Colorado State University | ||||||||||
| 408 University Svcs Center | Fort Collins | CO | 805232002 | 846000545 | 501(c)(3) | $188,128 | BASIC RESEARCH | |||
| Dana-Farber Cancer Institute Inc | ||||||||||
| 450 Brookline Avenue CLS 1017 | Boston | MA | 02215 | 042263040 | 501(c)(3) | $28,538 | BASIC RESEARCH | |||
| Emory University | ||||||||||
| 1599 Clifton Rd | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $342,000 | BASIC RESEARCH | |||
| Fred Hutchinson Cancer Research Center | ||||||||||
| 1100 Fairview Ave N C2-187 | Seattle | WA | 98109 | 237156071 | 501(c)(3) | $15,626 | BASIC RESEARCH | |||
| Icahn School of Medicine at Mount Sinai | ||||||||||
| One Gustave Levy Place | New York | NY | 10029 | 136171197 | 501(c)(3) | $60,000 | BASIC RESEARCH | |||
| Intercambios Puerto Rico | ||||||||||
| 660731885 | 501(c)(3) | $20,000 | PUBLIC POLICY | 165 Calle Diego Zalduondo Altos | Fajardo | RQ | ||||
| Johns Hopkins University | ||||||||||
| 733 N Broadway MRB Suite 117 | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $634,872 | BASIC RESEARCH, gmt initiative, treat asia | |||
| Massachusetts General Hospital | ||||||||||
| 55 Fruit Street | Boston | MA | 02114 | 042697983 | 501(c)(3) | $177,482 | BASIC RESEARCH | |||
| Mount Sinai Beth Israel | ||||||||||
| First Avenue at 16th Street | New York | NY | 10003 | 135564934 | 501(c)(3) | $22,500 | PUBLIC POLICY | |||
| New Hope for Cambodian Children | ||||||||||
| PO Box 690597 | Killeen | TX | 76549 | 205301015 | 501(c)(3) | $50,000 | TREAT ASIA | |||
| New York University | ||||||||||
| 545 First Avenue Greenberg Hall SC | New York | NY | 10016 | 135562308 | 501(c)(3) | $75,000 | BASIC RESEARCH | |||
| Northwestern University | ||||||||||
| 303E Superior Street Rm 9-159 | Chicago | IL | 60611 | 362167817 | 501(c)(3) | $55,385 | BASIC RESEARCH | |||
| Oregon Health and Science University | ||||||||||
| 3181 SW Sam Jackson Park Road | Portland | OR | 97239 | 931176109 | 501(c)(3) | $179,872 | BASIC RESEARCH | |||
| Regents of the University of California San Franc | ||||||||||
| 3333 California Street Suite 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $245,000 | BASIC RESEARCH | |||
| The George Washington University | ||||||||||
| 2121 I Street NW Suite 601 | Washington | DC | 20052 | 530196584 | 501(c)(3) | $22,498 | BASIC RESEARCH | |||
| The Rockefeller University | ||||||||||
| 1230 York Avenue | New York | NY | 10065 | 131624158 | 501(c)(3) | $1,075,000 | BASIC RESEARCH | |||
| The Scripps Research Institute | ||||||||||
| 10550 North Torrey Pines Road | La Jolla | CA | 92037 | 330435954 | 501(c)(3) | $15,626 | BASIC RESEARCH | |||
| The University of North Carolina at Chapel Hill | ||||||||||
| 104 Airport Drive CB 1350 | Chapel Hill | NC | 27599 | 566001393 | 501(c)(3) | $86,666 | BASIC RESEARCH | |||
| Trustees of the University of Pennsylvania | ||||||||||
| 422 Curie Blvd | Philadelphia | PA | 19104 | 231352685 | 501(c)(3) | $75,000 | BASIC RESEARCH | |||
| University of California Los Angeles | ||||||||||
| 11000 Kinross Avenue Suite 211 | Los Angeles | CA | 90095 | 956006143 | 501(c)(3) | $225,000 | BASIC RESEARCH | |||
| University of Nebraska-Lincoln | ||||||||||
| 151 Whittier Research Center 2200 | Lincoln | NE | 685830861 | 470049123 | 501(c)(3) | $60,000 | BASIC RESEARCH | |||
| University Of Pittsburgh | ||||||||||
| 123 University Place | Pittsburgh | PA | 15213 | 250965591 | 501(c)(3) | $163,804 | GMT INITIATIVE | |||
| University of Southern California | ||||||||||
| 2001 North Soto Street | Los Angeles | CA | 900899235 | 951642394 | 501(c)(3) | $90,000 | BASIC RESEARCH | |||
| University of Utah | ||||||||||
| 15 North Medical Drive East JMRB 21 | Salt Lake City | UT | 841125650 | 876000525 | 501(c)(3) | $60,000 | BASIC RESEARCH | |||
| University of Washington | ||||||||||
| 4333 Brooklyn Ave NE Box 359472 | Seattle | WA | 981959472 | 916001537 | 501(c)(3) | $60,000 | BASIC RESEARCH | |||
| Vaccine and Gene Therapy Institute Florida | ||||||||||
| 9801 SW Discovery Way | Port St Lucie | FL | 34987 | 364631835 | 501(c)(3) | $505,665 | BASIC RESEARCH | |||
| Veterans Medical Research Foundation | ||||||||||
| 3350 La Jolla Village Drive 151A | San Diego | CA | 921610002 | 330189397 | 501(c)(3) | $60,000 | BASIC RESEARCH | |||
| Worldwide Orphans Foundation | ||||||||||
| 515 Valley Street Suite 201 | Maplewood | NJ | 07040 | 133968225 | 501(c)(3) | $15,000 | TREAT ASIA | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 33 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Grants and Assistance | FormAndLineReferenceDesc |
| Explanation | Part I, Line 2 amfAR Provides grants and fellowships to independent not-for-profit organizations through a peer-review process. Grant applications are first reviewed by the Foundation's volunteer scientific advisory committee, which comprises recognized experts in the medical, scientific, and social sciences disciplines relevant to HIV and AIDS. The scientific advisory committee then sends its evaluations to one of the three committees (research, global initiatives or public policy) of the Foundation's program board, which serves in an advisory capacity to the Board of Trustees. After a program committee has completed its review of the applications, it presents its funding recommendations to amfAR's executive committee and/or the full Board of Trustees for final approval and funding authorization. Grants and fellowships are payable over a one-to-three-year period, and are revocable at amfAR's option if the recipient's performance or use of funds is not consistent with the terms of the grant or fellowships. In certain cases, the actual amounts paid under grants and fellowship awards may be less than the original award if the recipient does not use the full amount awarded. Therefore, a reserve for unexpended grants and fellowships has been recorded. Subawards are grants awarded to not-for-profit organizations to support the costs of collaboration and participation in HIV/AIDS-related research projects for which amfAR has secured restricted funds. Subawards are payable over a one-year period, although advance payments, in full or in part, may be issued following execution of the subaward agreement. Subawards are contingent upon the availability of funds and are revocable if the recipients' performance or use of funds is not consistent with the subaward terms. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (13 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kevin Frost | ||||||||||||||
| Chief Executive Officer | $394,276 | $0 | $0 | $0 | $126,083 | $0 | $35,700 | $0 | $51,109 | $0 | $607,168 | $0 | $59,500 | $0 |
| Bradley Jensen | ||||||||||||||
| Assistant Treasurer, CFO | $236,484 | $0 | $0 | $0 | $0 | $0 | $16,732 | $0 | $36,573 | $0 | $289,789 | $0 | $0 | $0 |
| John F Logan JD PhD | ||||||||||||||
| AssT Sec, Vp, GEN COUNSEL | $219,864 | $0 | $0 | $0 | $0 | $0 | $15,500 | $0 | $11,914 | $0 | $247,278 | $0 | $0 | $0 |
| Rowena Johnston | ||||||||||||||
| Asst Secretary, Vice President | $180,441 | $0 | $0 | $0 | $0 | $0 | $12,694 | $0 | $11,914 | $0 | $205,049 | $0 | $0 | $0 |
| Edward Donnelly | ||||||||||||||
| Asst Treasurer, Controller | $145,201 | $0 | $0 | $0 | $0 | $0 | $10,596 | $0 | $10,929 | $0 | $166,726 | $0 | $0 | $0 |
| Eric Muscatell | ||||||||||||||
| Vice President of Development | $197,610 | $0 | $0 | $0 | $0 | $0 | $14,024 | $0 | $11,914 | $0 | $223,548 | $0 | $0 | $0 |
| Annette Sohn | ||||||||||||||
| Vice President, TREAT Asia PGM | $225,322 | $0 | $0 | $0 | $0 | $0 | $15,373 | $0 | $6,032 | $0 | $246,727 | $0 | $0 | $0 |
| AnnMarie Shannahan | ||||||||||||||
| Vice President, Public Info. | $208,911 | $0 | $0 | $0 | $0 | $0 | $14,716 | $0 | $11,914 | $0 | $235,541 | $0 | $0 | $0 |
| Andrew McInness | ||||||||||||||
| Director, Publications | $148,469 | $0 | $0 | $0 | $0 | $0 | $10,682 | $0 | $36,573 | $0 | $195,724 | $0 | $0 | $0 |
| Anthony Ancona | ||||||||||||||
| Vice President, Human Resource | $167,055 | $0 | $0 | $0 | $0 | $0 | $11,828 | $0 | $11,906 | $0 | $190,789 | $0 | $0 | $0 |
| Susan Doster | ||||||||||||||
| Chief Technology Officer | $136,579 | $0 | $0 | $0 | $0 | $0 | $9,940 | $0 | $28,193 | $0 | $174,712 | $0 | $0 | $0 |
| Bennah Serfaty | ||||||||||||||
| Sr Director of CommunicatiON | $118,344 | $0 | $0 | $0 | $0 | $0 | $8,491 | $0 | $36,573 | $0 | $163,408 | $0 | $0 | $0 |
| Raoul Norman Tenazas | ||||||||||||||
| Creative Director | $114,699 | $0 | $0 | $0 | $0 | $0 | $8,359 | $0 | $36,573 | $0 | $159,631 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Compensation | FormAndLineReferenceDesc |
| Explanation | Part I, Line 4 Chief Executive Officer, Kevin Frost, participated in a supplemental nonqualified retirement plan. In calendar year 2014, Amfar contributed $60,000 into Mr. Frost's non-qualified retirement plan. This amount is not reported in Schedule J, Part II, Column (c) because the contributed amount was distributed to Mr. Frost within the same calendar year. Included in Schedule J column (b)(iii) is Mr. Frost's 2014 employer-funded 457(f) contribution of $60,000 plus payouts of previously contributed employer-funded 457(f) contributions (and earnings thereon). In Schedule J, part II, column (f), amfar is reporting $59,500 of 457(f) contributions that were recorded as deferred compensation on a previously filed Form 990. | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 20 | ContributionCnt |
| Noncash Contributions Rpt F990 | $631,638 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | sales price | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp | |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Form 990, Schedule M, line 31 | FormAndLineReferenceDesc |
| Explanation | To the extent that amFAR receives non-standard contributions, the organization's policy is to liquidate those items into cash for eventual use in support of the organization's mission. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Program Service Accomplishments(1) | Line 4a: Research: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. amfAR fellowships allow talented young investigators to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research. New Grants and Fellowships Grants and fellowships are awarded through a rigorous process of peer review by a team of independent HIV/AIDS experts drawn largely from the volunteer scientists on amfAR's Scientific Advisory Committee. Guided by its scientific advisors and with the approval of its board of trustees, amfAR pursues a strategic research plan that focuses on the pursuit of a cure for HIV/AIDS. Countdown to a Cure for AIDS In February 2015, amfAR outlined a $100 million investment strategy to support its Countdown to a Cure for AIDS initiative, which is aimed at developing the scientific basis for a cure by 2020. The strategy represents an unprecedented expansion of amfAR's grant making and is designed to provide support to any scientist or team of investigators for any research idea with the potential to advance the search for a cure, at any stage of its development. It is structured to provide sustained support for a wide range of studies that advance both emerging and established ideas. The strategy comprises the following components: - amfAR Institute for HIV Cure Research Launched at the end of 2015 at the University of California, San Francisco, the Institute will be the cornerstone of amfAR's cure research efforts and will be supported by a $20 million grant over five years. - Innovation Grants These two-year awards of up to $200,000 each will enable researchers to test innovative ideas supported by limited preliminary data. - Impact Grants These grants of up to $2 million each over four years will support the in-depth development of concepts already underpinned by preliminary data showing genuine potential for achieving a cure. - Investment Grants Aimed at recruiting the experience and expertise of scientists from outside the field of HIV, these $1 million grants will be awarded over a four-year period. Grantees may have expertise in fields such as cancer, neuroscience or inflammatory disease that can directly inform efforts to cure HIV. - ARCHE Launched in 2010, the amfAR Research Consortium on HIV Eradication, or ARCHE, supports collaborative teams of scientists in the U.S. and around the world working on a range of HIV cure strategies. - Opportunity Fund This funding mechanism will enable amfAR to respond quickly to emerging and unforeseen research opportunities. Innovation Grants In February 2015, amfAR's Board of Trustees approved the first round of 11 Innovation Grants totaling close to $2 million. Among them is a study by Dr. Benjamin Burwitz of Oregon Health and Science University in Portland that could help determine the precise mechanism of action that led to the first and only known HIV cure in the "Berlin Patient." Dr. Burwitz and colleagues plan to generate a non-human primate that will allow the testing of many hypotheses concerning the Berlin patient's cure, as well as, for example, gene therapy interventions designed to cure HIV. Another of these Innovation Grants was underwritten by generationCURE, a group of young professionals dedicated to supporting amfAR's cure-focused research. This inaugural $180,000 generationCURE grant was awarded to Dr. Brad Jones, assistant professor at George Washington University's Research Center for the Cure and Eradication of HIV, who is studying whether a novel combination therapy can eradicate the latent reservoirs of HIV that present a major barrier to finding a cure. Impact Grants In July amfAR awarded its first ever four-year grants at $2 million each. A team of researchers led by Dr. Dan Barouch of Beth Israel Deaconess Medical Center in Boston is investigating the ability of combinations of antibodies to specifically kill latently infected cells in the lab, in monkeys, and then in people. The researchers will test two promising antibodies alone and together, in combination with a newly described drug that can "shock" the virus out of latently infected cells and possibly enhance the ability of the antibodies to locate the infected cells. Dr. Timothy Henrich of the University of California, San Francisco, and his colleagues are pursuing a novel intervention aimed at restoring normal immune function in people with HIV. The team is testing whether the transplant drug, sirolimus, can increase the activity of beneficial components of the immune system while suppressing detrimental activity of other components. The team will thoroughly assess the drug's activities before moving on to test the drug on persistent HIV reservoirs in people. Using an approach that has already proved successful in cancer therapy, Dr. Sharon Lewin of the University of Melbourne, Australia, is exploring whether drugs that block so-called immune checkpoints can also be effective against HIV. Researchers theorize that the immune system cannot eliminate infected cells because of immune checkpoints, a set of mechanisms that limit the duration of an immune response so that the immune system does not become exhausted. Dr. Lewin and her team will test two drugs, alone and together, for their ability to reverse immune exhaustion and restore the ability of the immune system to eliminate infected cells. ARCHE In February the board approved a $1.5 million ARCHE (amfAR Research Consortium on HIV Eradication) grant to support a team of researchers from Rockefeller University in New York, Aarhus University Hospital in Denmark, and the University Hospital of Cologne, Germany. The researchers are testing the ability of the cancer drug Romidepsin, which has been shown to be effective at "shocking" HIV out of hiding, combined with an antibody to eliminate infected cells and thus reduce the size of the persistent HIV reservoir. Mathilde Krim Fellowships In October 2014, amfAR awarded an eighth round of Mathilde Krim Fellowships in Basic Biomedical Research, an initiative that provides funding for exceptional young researchers who are new to the field of HIV/AIDS research. The initiative has already achieved spectacular results, including numerous published studies in major scientific journals. Dr. Stylianos Bournazos of the Rockefeller University in New York is studying a range of antibody functions that could inform future vaccine design. Drs. David Schwefel of MRC National Institute for Medical Research in London and Spyridon Stavrou of the University of Pennsylvania are focusing on antiviral defenses within cells called restriction factors, which HIV has evolved to overcome, thus protecting itself from destruction. And Dr. Henning Hoffman of New York University is studying harmful overactivity of the immune system often caused by HIV infection, which can increase the risk of heart disease and other conditions. Published Research Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In the past year, 44 scientific publications resulted from amfAR-funded research. The Effects of Early Treatment Writing in the November 2014 issue of the Journal of Infectious Diseases, amfAR grantees Dr. Katherine Luzuriaga of the University of Massachusetts Medical School, Dr. Deborah Persaud of Johns Hopkins University, and colleagues reported on eight children who were perinatally infected with HIV and then followed for up to 18 years. Four were treated with ART shortly after birth, while the other four, in keeping with treatment guidelines in place at the time of their infection, did not receive ART until 6 to 15 years of age. Most striking was the fact that all four treated early had lower levels of proviral DNA-one measure of HIV reservoir size-along with decreased T-cell activation and absent or minimal anti-HIV immune responses, which is another indication of vanishingly small levels of virus in their bodies. Drs. Luzuriaga, Persaud, and associates concluded that "life-long therapy may not be necessary for all individuals, particularly those who initiate cART during primary infection." When Is the Reservoir Established? Writing in the January issue of Current Opinion in HIV and AIDS, Dr. Nicolas Chomont of the Vaccine and Gene Therapy Institute in Florida and associates from the U.S. Military HIV Research Program and t |
| Program Service Accomplishments (2) | Line 4b: TREAT ASIA: amfAR's TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies. The TREAT Asia Network encompasses 21 adult and 18 pediatric sites throughout the region, which collaborate on a variety of projects. TREAT Asia scientists published 28 publications in peer-reviewed medical journals in FY2015. TREAT Asia HIV Observational Database (TAHOD) TREAT Asia pioneered the region's first adult observational database for HIV/AIDS, which now includes anonymous data collected from approximately 9,000 patients at 21 clinical sites in 12 countries. The information gathered and analyzed through the database informs the development of more effective research and treatment programs, and helps define treatment standards specific to HIV/AIDS in Asia. TAHOD-Lite While TAHOD continues to be an essential resource for assessing treatment outcomes in Asian populations, its model of in-depth data collection limits the size of the cohort to a subset of those living with HIV who are cared for at the participating clinics. In FY2015, TREAT Asia launched a new database called TAHOD-Lite that includes more basic data but from a much larger proportion of the HIV-positive patients seen at participating sites. International AIDS Database TREAT Asia manages the Asia-Pacific section of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), a global collaboration established by the U.S. National Institute of Allergy and Infectious Diseases. In FY2015, the IeDEA consortium launched a new study aiming to develop and validate a standardized tool to measure and better understand adherence among young people. The study is building on research already done by an IeDEA site in Kenya. TREAT Asia is working with HIV-NAT at the Thai Red Cross AIDS Research Centre to conduct a Thai component. The study will employ and evaluate a brief standard questionnaire that can accurately assess young people's adherence to treatment. It will also examine current adherence among children at the three participating IeDEA sites in Kenya, South Africa, and Thailand, evaluate factors that increase the risk of non-adherence, and assess the impact of non-adherence on treatment failure and clinic dropout. TREAT Asia Pediatric Network TREAT Asia's Pediatric Network includes 18 sites in six countries; these sites share information and best practices in an effort to improve the quality of pediatric care in the region. The TREAT Asia Pediatric HIV Observational Database (TApHOD) was modeled on the adult database and includes data from approximately 5,500 pediatric patients in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. TREAT Asia has been following a prospective cohort study of 248 HIV-infected adolescents to evaluate multiple social, cultural, and behavioral factors that affect ART adherence using an audio computer-assisted self-interview (ACASI) instrument at nine TApHOD sites in Malaysia, Thailand, and Vietnam. Among the study findings were that adolescents with effective virologic suppression were less likely to report high-risk sexual behaviors, such as inconsistent condom use. This emphasizes the need to promote and support strategies to achieve viral suppression as a key priority for adolescents who are struggling to remain adherent to ART. This study was supported by the AIDS Life Foundation. Additional Adolescent Research In FY2015, TREAT Asia conducted and continued several studies aimed at improving the health and well-being of adolescents living with HIV. HIV-NAT/Thai Red Cross AIDS Research Centre, in collaboration with three other clinical sites in Thailand, conducted a study of whether technology-based interventions, in this case short messaging service (SMS) reminders, can increase adherence to antiretroviral therapy among adolescents. This study received support from ViiV Healthcare. TREAT Asia conducted the third year of its study to evaluate the natural history of HPV infection and risk factors for HPV acquisition and persistence among perinatally HIV-infected individuals compared to uninfected female and male adolescents in Thailand and Vietnam. The findings, which were presented at the International Workshop on HIV Pediatrics in July 2015, support the need for greater integration of preventive sexual health services into HIV care programs for young women with HIV, and more effective linkages between existing healthcare programs supporting adolescents. This study was supported by the AIDS Life Foundation. Expanding Pre-Exposure Prophylaxis (PrEP) for HIV in Thailand In 2015, in an effort to enhance national HIV prevention efforts, the Thai Red Cross AIDS Research Centre and Adam's Love, Thailand's leading Internet and social media-based HIV outreach initiative, began working on two groundbreaking efforts to bring oral pre-exposure prophylaxis (PrEP) to MSM in Thailand. Both projects are supported in part by TREAT Asia. Adam's Love's PrEP-30 campaign is Thailand's first major effort to spread awareness about PrEP and how it works and encourage MSM who are at higher risk of HIV infection to consider using it. Dr. Nittaya Phanuphak is leading a Thai Red Cross study on the uptake and efficacy of PrEP among Thai MSM and hopes the findings from her research will encourage the Thai government to cover the cost of PrEP under Thailand's national health insurance. Exploring Links Between HIV and Cancer Because MSM living with HIV are twice as likely as those without HIV to develop the anal cancer associated with human papillomavirus (HPV), the Anonymous Clinic of the Thai Red Cross AIDS Research Centre, a TREAT Asia network member in Bangkok, started screening its patients for anal precancers. Using funding from amfAR's GMT Initiative, they purchased the high-resolution anoscopy microscope necessary to diagnose and treat both anal warts and precancerous anal lesions, and began providing anal Pap smears and treatment free of charge. This not only benefited their patients, it also generated some of the first data about HPV and anal neoplasia-the final stage the lesions reach before developing into cancer-among MSM in a resource-limited setting in the Asia-Pacific. With support from TREAT Asia, the AIDS Life Foundation, the U.S. National Institutes of Health, and the University of California, San Francisco, three additional TREAT Asia sites in Indonesia and Malaysia have established similar programs. Building Community Treatment Literacy and Promoting Advocacy for Treatment Access TREAT Asia works closely with regional organizations to support treatment literacy activities, including the production of "community-friendly" educational brochures on HIV treatment standards in local languages. In 2015, with support from ViiV Healthcare's new Positive Action for Adolescents program, TREAT Asia launched a program called Youth ACATA (Asia Community for AIDS Treatment and Advocacy) in an effort to mobilize HIV-positive youth across the region. It held three Youth ACATA workshops for young people living with HIV from Cambodia, Indonesia, Thailand, and Vietnam in an effort to mobilize youth HIV advocacy across the region, among other trainings. TREAT Asia also released a policy brief urging governments, public health authorities, healthcare providers, and civil society in Asia to address persistent gaps in women's access to reproductive health services, especially for women living with HIV in the region. Sexual and Reproductive Health of HIV-Positive Women in Asia: A Policy Framework for the Future provides recommendations aimed at closing gaps in the delivery of HIV prevention and care in Asia. In August 2015, Adam's Love launched Adam's Love Taiwan, its fourth country-specific HIV outreach campaign targeting at-risk populations through its unique online edutainment approach that combines educational HIV resources with videos and social media posts from national celebrities. (Adam's Love is supported by ViiV and amfAR, and sponsored by the Thai Red Cross AIDS Research Centre.) Adam's Love's other three edutainment projects-Adam's Love Thailand and TemanTeman.org Indonesia and Malaysia-have all been highly successful, garnering a total of nearly three million unique visitors to their websites. Adam's Love is partnering with three additional GMT-friendly clinics in the country to help individuals in Taiwan access convenient, discrimination-free VCT services. They aim to continue to expand across the region, with plans to launch websites in South Korea in 2016 and Japan by 2017. In addition, TREAT Asia continued to publish lay-language articles on AIDS research, policy, and community issues facing the TREAT Asia network and the Asia-Pacific as a whole. It also |
| Program Service Accomplishments (3) | Line 4c: EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. Educational Materials amfAR produces a range of periodicals in both print and electronic formats, including its newsletter Innovations, published twice a year and distributed to more than 45,000 people; the TREAT Asia Report, an e-mail newsletter distributed six times a year to more than 4,000 readers in the international health community; and a monthly e-mail newsletter distributed to nearly 100,000 people. The Foundation's website features news, interviews, blog posts, and other original articles covering science, policy, the global epidemic, and amfAR programs and activities. The website attracts an average 30,000 visitors per month. amfAR also creates and distributes program reports, press releases, and updates on major HIV/AIDS issues and conducts public service advertising campaigns that have been instrumental in educating policymakers, healthcare professionals, people living with HIV/AIDS, and the general public. Social Media amfAR vigorously expanded its presence in the social media arena, reaching large numbers of people, including a younger demographic that is often less educated about HIV and the AIDS epidemic. The Foundation regularly added content to its Facebook page and live tweeted and posted images on Instagram from fundraising and program events. amfAR has 67,000 likes on Facebook, 35,400 Twitter followers, and more than 81,000 Instagram followers. Media Outreach amfAR continued to work closely with the media to raise the profile of HIV/AIDS, both domestically and internationally, and to help ensure the accuracy of AIDS-related press coverage. Articles and reports involving amfAR-many of which included interviews with amfAR staff and spokespeople-were carried in numerous media outlets, including the New York Times, The Wall Street Journal, The Washington Post, and The Huffington Post, and news agencies such as the Associated Press, CNN, Bloomberg News, and Reuters. amfAR's public awareness efforts are greatly enhanced by the committed support of public figures who lend their voices and donate their time, talents, and resources to help sustain the Foundation's mission. Support of amfAR by prominent public figures began with the late Dame Elizabeth Taylor, and others have followed in her footsteps. amfAR is profoundly grateful for the continuing steadfast support of Global Campaign Chair Sharon Stone. In FY2015 Scarlett Johansson donated her time to record a voiceover for an amfAR video promoting its Countdown to a Cure for AIDS initiative. Other celebrity supporters included amfAR Ambassadors Milla Jovovich and Michelle Yeoh, Miley Cyrus, Dita Von Teese, Rihanna, Justin Timberlake, Tom Ford, Gwyneth Paltrow, Chiara Ferragni, Ryan Murphy, Lisa Kudrow, Rose McGowan, Jay Ellis, Eddie Redmayne, Lea Michele, Michelle Rodriguez, Rosario Dawson, Whoopi Goldberg, Chris Rock, amfAR Trustee Harry Belafonte, Naomi Campbell, Iman, Heidi Klum, Brooke Shields, Coco Rocha, Kate Moss, Cher, Kylie Minogie, Riccardo Tisci, Adrien Brody, Eva Longoria, Harvey Keitel, Harvey Weinstein, Leonardo DiCaprio, Robin Thicke, Rita Ora, Andrea Bocelli, Dean and Dan Caten, Chris Tucker, Mario Testino, Carine Roitfeld, Aishwarya Rai Bachchan, Laverne Cox, Anderson Cooper, Sandra Bernhard, Andy Cohen and Mr. Brainwash. |
| Program Service Accomplishments (4) | Line 4d: THE GMT INITIATIVE: Since 2007, amfAR has been serving the HIV-related needs of gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) throughout the developing world through its GMT Initiative. Through small, targeted grants to grassroots groups, amfAR has expanded access to HIV education and prevention services; supported advocacy aimed at increasing funding for prevention and treatment services; and worked to end the stigma, discrimination, and violence that threaten the lives of GMT and fuel the spread of HIV/AIDS. In January 2015, amfAR supported a study at Instituto Pesquisa Clinica Evandro Chagas (IPEC) in Rio de Janeiro, Brazil, one of 16 clinical sites participating in the Opposites Attract Study, an ongoing international study that explores the effectiveness of "treatment as prevention" in gay male serodiscordant relationships (one sexual partner is living with HIV and the other is not). The study is led by Dr. Beatriz Grinsztejn, director of the STD/AIDS Clinical Research Laboratory at IPEC, who is monitoring as many as 70 gay male serodiscordant couples in Brazil and examining HIV treatment, viral loads, and HIV transmission to find out if HIV incidence is associated with whether the HIV-positive partner is on antiretroviral therapy. Implementation Science Awards In FY2015, the focus of amfAR's grant making through the GMT Initiative evolved from the distribution of small grants to community-based organizations to the support of larger implementation science projects aimed at identifying barriers to HIV testing, treatment and care, and studying the impact of innovative HIV service delivery models for GMT in low- and middle-income countries. amfAR awarded $2.6 million over three years to support three such studies. Dr. Chris Beyrer of Johns Hopkins University is leading a team of researchers and community-based services (in collaboration with the International HIV/AIDS Alliance Myanmar) in evaluating the effectiveness of promising interventions for GMT in Myanmar, where increased HIV testing and treatment opportunities are becoming available. The researchers will assess the effectiveness of HIV self-testing done in the privacy of one's home, point-of-care CD4 testing, and the use of "peer navigators" familiar with the local health system to help those newly diagnosed gain access to HIV treatment and care. In Lima, Peru, Dr. Javier Lama of Asociacin Civil Impacta Salud y Educacin and his team aim to improve the continuum of care among transgender women by using an innovative model that integrates HIV prevention and treatment services with transgender-affirming medical care. Working in collaboration with the Boston-based Fenway Institute and two community GMT organizations, IMPACTA and EPICENTRO, Dr. Lama and his team will integrate routine cross-sex hormone therapy into HIV and sexually transmitted infection prevention, testing and treatment services, and will implement health services and peer case management for 200 transgender women. And in Bangkok, Thailand, Dr. Nittaya Phanuphak and her team at the Thai Red Cross AIDS Research Centre aim to show how innovative technologies such as GMT-targeted websites using online counseling and support can be utilized to increase rates of HIV testing and referrals to prevention and treatment programs. Working in collaboration with Adam's Love, a web-based health platform for GMT individuals, and two community-based organizations (Service Workers in Group/SWING and The Rainbow Sky Association of Thailand), the team will compare the effectiveness of online services and support interventions with traditional clinic-based HIV services, and a hybrid model that combines elements of both strategies. "In Action" Awards In 2015 amfAR supported five community-based organizations in Africa and Latin America in conducting formalized evaluations of their efforts to improve HIV treatment and care among GMT individuals as part of the GMT Initiative's Evidence in Action Program, which documents and evaluates the impact of community-based programs with the ultimate goal of implementing the most workable strategies for stopping the spread of HIV/AIDS. Evidence in Action was developed with support from ViiV Healthcare's Positive Action program and the Elton John AIDS Foundation. amfAR also supported four young researchers from Belize, China, Pakistan, and South Africa undergoing five months of graduate-level public health study at the Center for LGBT Health Research of the Graduate School of Public Health at the University of Pittsburgh as part of the amfAR HIV Scholars Program. The program aims to strengthen GMT community-based research and responses to HIV, often in areas where little data about HIV among GMT currently exist and where stigma and discrimination deter many GMT from seeking HIV testing and services. The 2015 amfAR HIV Scholars included Sheryar Kazi with the Naz Male Health Alliance, Pakistan; Liesl Theron, a consultant supported by Gender DynamiX, South Africa; Erika Castellanos from the Collaborative Network of Persons Living with HIV (C-NET+), Belize; and Weibin Cheng from the Chinese Center for Disease Control and Prevention and GZTZ.org. Publications As part of its efforts to raise awareness among governments, donors, and international nongovernmental organizations about the spread of HIV among GMT individuals and to advocate for effective strategies to address it, amfAR publishes a range of reports on HIV and GMT. In FY2015, the Foundation published Lessons From the Front Lines: Trans Health and Rights. The report, produced in collaboration with Global Action for Trans Equality (GATE), profiled 10 dynamic community organizations with strong transgender leadership in nine diverse countries-Bolivia, China, the Dominican Republic, Ecuador, El Salvador, Georgia, Peru, South Africa, and Ukraine-that are working hard to change the status quo in transgender health and rights. With support from the Arcus Foundation, the report examined data on access to health services and legal protections for transgender individuals in different settings and detailed how societal stigma and institutionalized discrimination come together to create nearly insurmountable challenges for these populations and the organizations that serve them. More importantly, however, the report described how these grassroots groups have confronted, responded to, and in some cases solved, many of the myriad challenges they face. The GMT Initiative also created a series of fact sheets in English, French, and Spanish on emerging HIV prevention technologies that explain each technology and serve as a tool to help GMT advocate for the interventions' increased availability worldwide. |
| Program Service Accomplishments (5) | Line 4d: public policy: Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research; implement the U.S. National HIV/AIDS Strategy; expand access to care and treatment; and protect the civil rights of all people affected by HIV/AIDS. Capitol Hill Briefings In March 2015, amfAR held a Congressional briefing in Washington, D.C., to illuminate the work that remains to be done to achieve an AIDS-free generation among women and girls in the U.S. and globally. The Capitol Hill briefing drew leaders from government, academia, and the nonprofit sector, including House Democratic Leader Nancy Pelosi, Jeannette Kagame, First Lady of Rwanda and cofounder of the Organization of African First Ladies Against HIV/AIDS, and Dr. Deborah Birx, U.S. Global AIDS Coordinator. The program also addressed medical research aimed at improving HIV prevention for women. Dr. Sharon Hillier of the University of Pittsburgh School of Medicine shared exciting progress on female-controlled HIV prevention methods, including vaginal rings containing antiretroviral (ARV) medicines, which have been shown to reduce infection rates in women 25 years of age and older. Other attendees included Reps. Nita M. Lowey and Barbara Lee, Douglas Brooks, director of the White House Office of National AIDS Policy, and Maria Cuomo Cole, chairman of HELP USA, which provides housing and other services to the homeless. Shaping the Domestic Response to HIV/AIDS amfAR has long advocated the implementation of a comprehensive national HIV/AIDS strategy to address the epidemic in the U.S., where more than 1.2 million people are living with the virus. In July 2015, amfAR issued a report titled Bolstering State Efforts to Implement the National HIV/AIDS Strategy: Key Indicators and Recommendations for Policymakers and Community Stakeholders. The report outlined recommendations for how states across the U.S. can improve their HIV prevention and care responses. It was released to coincide with the White House's 2015 update to the Strategy. In FY2015, the Foundation also produced issue briefs, fact sheets, special reports, and infographics on multiple critical issues, including addressing HIV among women, better responding to HIV among black gay men in the U.S., advocating harm reduction interventions to prevent the spread of HIV among PWID, and making the case for better access to hepatitis C treatment. Key Populations In February 2015, amfAR published an issue brief showing that efforts to address the HIV epidemic among black gay men have been consistently inadequate and that immediate steps must be taken to reduce new HIV infections among this underserved population. The report, titled HIV and the Black Community: Do #Black (GAY) Lives Matter? described the underlying factors contributing to elevated infection rates among black men and provided a list of steps that can be taken to mitigate this stark and persistent racial disparity. In conjunction with its Capitol Hill briefing on women and HIV in March, amfAR released a pair of issue briefs on women and HIV/AIDS in the United States and around the world. The briefs outlined policy action steps to achieve an AIDS-free generation and help more women living with the disease in the U.S. to survive and thrive. Harm Reduction/Syringe Services Programs As one of the earliest supporters of comprehensive harm reduction programs for people who inject drugs (PWID), including syringe exchange, amfAR has played a leading role in advocating the implementation of these lifesaving HIV prevention programs. In April 2015, amfAR issued a brief titled Preventing HIV and Hepatitis C Among People Who Inject Drugs: Public Funding for Syringe Services Programs Makes the Difference. In it, amfAR underscored the importance of syringe service programs (SSPs) as a highly effective tool in the fight against the spread of HIV and hepatitis C. CEO Kevin Robert Frost also authored an op-ed on the issue for CNN.com. Another issue brief published in May and titled A Clear Case for Supporting Syringe Services Programs: New Study Shows Relationship Between Public Funding and Lower HIV Incidence, was based on a study that found a relationship between public funding of syringe services programs, reducing HIV incidence (the number of new infections in a given year), and maintaining already low HIV incidence among PWID. In its Harm Reduction and Global HIV Epidemic report, released in September 2015, amfAR assessed the state of harm reduction worldwide by focusing on the steps that five sample countries-Kenya, Kyrgyzstan, Nigeria, Ukraine, and Vietnam-have, or have not, taken to address the epidemic among PWID. Treatment Access In Trans-Pacific Partnership: Curbing Access to Medicines Now and in the Future, an issue brief published in May 2015, amfAR strongly opposed the proposed terms of the Trans-Pacific Partnership, warning that expanding existing intellectual property protections could result in a decline in generic competition and an increase in drug costs, while setting an unacceptable precedent for future free trade agreements. Two agreements being negotiated threaten the future availability of affordable generic medicines for diseases such as HIV/AIDS, cancer, tuberculosis, and hepatitis C, and could undermine the global health response in developing countries. In a February 2015 policy brief titled Hepatitis C and Drug Pricing: The Need for Better Balance, amfAR called for structural changes that alter the pricing incentives for pharmaceutical companies in such a way that they cannot charge extortionate prices for their products, however effective they may be. New pharmaceutical breakthroughs have made curing hepatitis C infection easier and more effective, but they have been priced at aggressively high rates that bear no relation to the cost of research and development. Global Health In FY 2015, amfAR launched its PEPFAR Country/Regional Operational Plan database, a comprehensive, navigable database of PEPFAR's planned funding of HIV/AIDS activities from 2007 to 2014. PEPFAR (the U.S. President's Emergency Plan for AIDS Relief), established in 2003, is the largest international program responding to the global HIV/AIDS epidemic and the largest commitment one nation has ever made to combat a disease internationally. The database enables users to analyze planned funding data extracted from PEPFAR's publicly released Country and Regional Operational Plan (COP/ROP) documents. It's designed to help civil society organizations, ministries of health and finance, researchers, and other stakeholders to access and understand PEPFAR's programs and priorities at a deeper level than is currently possible using other platforms. |
| Policies | form 990, part vi, section b Line 11 - The Form 990 was prepared by a nationally renowned accounting firm in conjunction with the organization's financial department. A copy of the draft Form 990 was circulated to the full Board of Trustees for discussion and comment. Each Board Member was provided ample opportunity to comment on the information contained in the 990 prior to its filing with the Internal Revenue Service. Line 12 - Each officer, director, trustee and key employee of amFar ("foundation") is required to annually disclose any conflicts of interest that arise by virtue of employment, board service, or position with the foundation. The foundation monitors compliance with its conflict of interest policy through an annual questionnaire/disclosure statement that is distributed to these individuals. Potential conflicts are investigated immediately. LINE 15 -AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS. |
| Disclosure | Form 990, Part VI, Section C LIne 19 - amfar makes its Form 990 available to the public by retaining a copy at its place of business and on its website, www.amfar.org. The Form 990 is likewise published on the internet at www.guidestar.org. The Foundation's financial statements are made available in its annual report and on its website. The Foundation's governing documents and conflict of interest policy are not ordinarily made available to the public, but, if requested, will be provided at management's discretion. |
| Functional Expenses | Part IX, Lines 1 & 3 The Foundation for AIDS Research reports its grants net of grant returns or recoveries. Periodically, grants remitted to charitable organizations are returned to AMFAR for a variety of reason. On Schedules F & I, grants are reported irrespective of whether they were ultimately returned to AMFAR since categorizing the "returned" amounts would be time consuming. Therefore, amounts reported on Part IX, Line 1 will not tie to total grants on Schedule I; amounts reported on Part IX, Line 3 will not tie to total grants on Schedule F. |
| Other Changes in Net Assets | FORM 990, SECTION XI, LINE 5 CHANGE IN VALUE OF THIRD PARTY TRUST............$2,556 ------- TOTAL LINE 9 $2,556 |
Comments